Publications

Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME (2019)
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol (in press)
DOI 10.1007/s00345-019-02837-0, PubMed 31183524

Rud E, Langberg CW, Baco E, Lauritzen P, Sandbæk G (2019)
MRI in the Follow-up of Testicular Cancer: Less is More
Anticancer Res, 39 (6), 2963-2968
DOI 10.21873/anticanres.13427, PubMed 31177136

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2018)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 118 (6), e11
DOI 10.1038/bjc.2017.470, PubMed 29462127

Fan ZR, Li LF, Li XL, Zhang M, Zhong YL, Li YQ, Yu DD, Cao J, Zhao J, Deng XM, Zhang MZ, Wen JG, Liu ZS, Goscinski MA, Berge V, Nesland JM, Suo ZH (2018)
Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet
RSC Adv., 8 (30), 16636-16644

Hompland T, Hole KH, Ragnum HB, Aarnes EK, Vlatkovic L, Lie AK, Patzke S, Brennhovd B, Seierstad T, Lyng H (2018)
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
Cancer Res, 78 (16), 4774-4785
DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958

Johnson I, Ottosson F, Diep LM, Berg RE, Hoff JR, Wessel N, Eri LM, Berge V (2018)
Switching from laparoscopic radical prostatectomy to robot assisted laparoscopic prostatectomy: comparing oncological outcomes and complications
Scand J Urol, 52 (2), 116-121
DOI 10.1080/21681805.2017.1420099, PubMed 29334304

Kløw NE, Grøtta OJ, Bay D, Sandbæk G, Johansen TEB, Hagen T, Baco E (2018)
Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
Acta Radiol, 60 (9), 1175-1180
DOI 10.1177/0284185118813709, PubMed 30450921

Mariathasan AB, Boye K, Giercksky KE, Brennhovd B, Gullestad HP, Emblemsvåg HL, Grøholt KK, Dueland S, Flatmark K, Larsen SG (2018)
Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement
Eur J Surg Oncol, 44 (8), 1226-1232
DOI 10.1016/j.ejso.2018.03.029, PubMed 29691115

Medlow PW, Steele CJ, McCavigan AM, Reardon W, Brown CM, Lambe SM, Ishiy FAA, Walker SM, Logan GE, Raji OY, Berge V, Katz B, Kay EW, Sheehan K, Watson RW, Harkin DP, Kennedy RD, Knight LA (2018)
Analytical validation of a prognostic prostate cancer gene expression assay using formalin fixed paraffin embedded tissue
BMC Med Genomics, 11 (1), 125
DOI 10.1186/s12920-018-0442-y, PubMed 30591067

Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T et al. (2018)
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients
Int J Urol, 25 (12), 990-997
DOI 10.1111/iju.13796, PubMed 30187529

Prencipe M, Fabre A, Murphy TB, Vargyas E, O'Neill A, Bjartell A, Tasken KA, Grytli HH, Svindland A, Berge V, Eri LM, Gallagher W, Watson RW (2018)
Role of serum response factor expression in prostate cancer biochemical recurrence
Prostate, 78 (10), 724-730
DOI 10.1002/pros.23516, PubMed 29608018

Rud E, Diep L, Baco E (2018)
A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient
World J Urol, 36 (4), 629-637
DOI 10.1007/s00345-018-2171-4, PubMed 29349572

Rud E, Lauritzen P, Baco E (2018)
Re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722-8
Eur Urol, 75 (4), e103
DOI 10.1016/j.eururo.2018.11.047, PubMed 30528223

Stranne J, Brasso K, Brennhovd B, Johansson E, Jäderling F, Kouri M, Lilleby W, Meidahl Petersen P, Mirtti T, Pettersson A, Rannikko A, Thellenberg C, Akre O (2018)
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer
Scand J Urol, 52 (5-6), 313-320
DOI 10.1080/21681805.2018.1520295, PubMed 30585526

Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
World J Urol, 37 (8), 1571-1580
DOI 10.1007/s00345-018-2570-6, PubMed 30483947

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, and the Prostate Cancer RCT Consensus Group (2017)
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?
Nat Rev Clin Oncol (in press)
DOI 10.1038/nrclinonc.2017.86, PubMed 28895571

Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
BMC Urol, 17 (1), 111
DOI 10.1186/s12894-017-0302-7, PubMed 29197360

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346, PubMed 28972967

Eri LM (2017)
Skriveri om urologi
Tidsskr Nor Laegeforen, 137 (22)
DOI 10.4045/tidsskr.17.0710, PubMed 29181947

Hansen BT, Orumaa M, Lie AK, Brennhovd B, Nygård M (2017)
Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015
Int J Cancer, 142 (8), 1586-1593
DOI 10.1002/ijc.31194, PubMed 29205336

Idland AV, Wyller TB, Støen R, Eri LM, Frihagen F, Ræder J, Chaudhry FA, Hansson O, Zetterberg H, Blennow K, Bogdanovic N, Brækhus A, Watne LO (2017)
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
J Alzheimers Dis, 55 (1), 371-379
DOI 10.3233/JAD-160461, PubMed 27662296

Li X, Grigalavicius M, Li Y, Li X, Zhong Y, Huang R, Yu D, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells
Tumour Biol, 39 (8), 1010428317713671
DOI 10.1177/1010428317713671, PubMed 28789597

Li X, Han G, Li X, Kan Q, Fan Z, Li Y, Ji Y, Zhao J, Zhang M, Grigalavicius M, Berge V, Goscinski MA, Nesland JM, Suo Z (2017)
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
Oncotarget, 8 (28), 46363-46380
DOI 10.18632/oncotarget.18199, PubMed 28624784

Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Sci Rep, 7 (1), 5081
DOI 10.1038/s41598-017-05086-6, PubMed 28698547

Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A (2017)
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
Mol Cancer, 16 (1), 156
DOI 10.1186/s12943-017-0726-4, PubMed 28982366

Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW et al. (2017)
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
Eur Urol, 72 (4), 509-518
DOI 10.1016/j.eururo.2017.03.027, PubMed 28408174

Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
Urology, 110, 140-147
DOI 10.1016/j.urology.2017.07.048, PubMed 28823634

Baco E, Rud E, Vlatkovic L (2016)
Reply to Yi Zhou, Weigang Yan, and Hanzhong Li's Letter to the Editor re: Eduard Baco, Erik Rud, Lars Magne Eri, et al. A Randomized Controlled Trial to Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy. Eur Urol 2016;69:149-56
Eur Urol, 70 (2), e55
DOI 10.1016/j.eururo.2016.01.031, PubMed 26852076

Bigot P, Bernhard JC, Flamand V, Gill I, Verhoest G, Beauval JB, Nouhaud FX, Suer E, Ploussard G, Hetet JF, Rigaud J, Baco E, Larré S, Sebe P, Koutlidis N, Descazeaud A, Eto M, Doerfler A, Roupret M, Vuong NS, Reix B, Matsugasumi T, Bakri AE, Albiges L, Soulié M et al. (2016)
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes
Urol Oncol, 35 (1), 35.e15-35.e19
DOI 10.1016/j.urolonc.2016.08.012, PubMed 27692834

Bokhorst LP, Lepistö I, Kakehi Y, Bangma CH, Pickles T, Valdagni R, Alberts AR, Semjonow A, Strölin P, Montesino MF, Berge V, Roobol MJ, Rannikko A (2016)
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
BJU Int, 118 (3), 366-71
DOI 10.1111/bju.13410, PubMed 26765682

Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
Oncotarget, 7 (2), 1878-94
DOI 10.18632/oncotarget.6479, PubMed 26646591

Drejer D, Béji S, Oezeke R, Nielsen AM, Høyer S, Bjerklund Johansen TE, Lam GW, Jensen JB (2016)
Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study
Urology, 102, 138-142
DOI 10.1016/j.urology.2016.11.032, PubMed 27894979

Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA (2016)
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
Scand J Urol, 50 (4), 280-5
DOI 10.3109/21681805.2016.1163617, PubMed 27049891

Moen LV, Ramberg H, Zhao S, Grytli HH, Sveen A, Berge V, Skotheim RI, Taskén KA, Skålhegg BS (2016)
Observed correlation between the expression levels of catalytic subunit, Cβ2, of cyclic adenosine monophosphate-dependent protein kinase and prostate cancer aggressiveness
Urol Oncol, 35 (3), 111.e1-111.e8
DOI 10.1016/j.urolonc.2016.10.002, PubMed 27838142

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA (2016)
PBX3 is a putative biomarker of aggressive prostate cancer
Int J Cancer, 139 (8), 1810-20
DOI 10.1002/ijc.30220, PubMed 27273830

Rud E, Baco E (2016)
Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40: Is Contrast-enhanced Magnetic Resonance Imaging Really Necessary When Searching for Prostate Cancer?
Eur Urol, 70 (5), e136
DOI 10.1016/j.eururo.2016.04.017, PubMed 27126376

Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, Berge V, Sandvig K, Llorente A (2016)
Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
Eur J Cancer, 70, 122-132
DOI 10.1016/j.ejca.2016.10.011, PubMed 27914242

Wang L, Skotland T, Berge V, Sandvig K, Llorente A (2016)
Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation
Eur J Pharm Sci, 98, 80-85
DOI 10.1016/j.ejps.2016.09.023, PubMed 27664330

Østby-Deglum M, Axcrona K, Brennhovd B, Dahl AA (2016)
Ability to Reach Orgasm in Patients With Prostate Cancer Treated With Robot-assisted Laparoscopic Prostatectomy
Urology, 92, 38-43
DOI 10.1016/j.urology.2015.11.066, PubMed 26972145

Baco E, Rud E, Eri L, Oen G, Latkovic L, Svindland A, Eggesbø H, Ukimura O (2015)
[Not Available]
Prog Urol, 25 (13), 832-3
DOI 10.1016/j.purol.2015.08.231, PubMed 26544425

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eur Urol, 69 (1), 149-56
DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143

Bernhard JC, Isotani S, Matsugasumi T, Duddalwar V, Hung AJ, Suer E, Baco E, Satkunasivam R, Djaladat H, Metcalfe C, Hu B, Wong K, Park D, Nguyen M, Hwang D, Bazargani ST, de Castro Abreu AL, Aron M, Ukimura O, Gill IS (2015)
Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education
World J Urol, 34 (3), 337-45
DOI 10.1007/s00345-015-1632-2, PubMed 26162845

Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gökce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Léon P, Bakri AE, Larré S, Tillou X et al. (2015)
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
World J Urol, 34 (3), 347-52
DOI 10.1007/s00345-015-1634-0, PubMed 26149352

Eri LM (2015)
[Re: Implementation of guidelines for PSA testing in general practice]
Tidsskr Nor Laegeforen, 135 (1), 15
DOI 10.4045/tidsskr.14.1494, PubMed 25589118

Matsugasumi T, Baco E, Palmer S, Aron M, Sato Y, Fukuda N, Süer E, Bernhard JC, Nakagawa H, Azhar RA, Gill IS, Ukimura O (2015)
Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume
J Urol, 194 (4), 957-65
DOI 10.1016/j.juro.2015.04.075, PubMed 25912496

Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
Eur Urol, 68 (3), 487-96
DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692

Solberg A, Angelsen A, Berge V, Lilleby W, Iversen J, Klepp O, Brennhovd B, Johannessen D, Nygård Y, Larsen K, Stensvold A (2015)
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (12-13), 1105
DOI 10.4045/tidsskr.15.0652, PubMed 26130530

Østby-Deglum M, Brennhovd B, Axcrona K, Fosså SD, Dahl AA (2015)
A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy
Scand J Urol, 49 (6), 433-439
DOI 10.3109/21681805.2015.1042038, PubMed 26116048

Øverbye A, Skotland T, Koehler CJ, Thiede B, Seierstad T, Berge V, Sandvig K, Llorente A (2015)
Identification of prostate cancer biomarkers in urinary exosomes
Oncotarget, 6 (30), 30357-76
DOI 10.18632/oncotarget.4851, PubMed 26196085

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M, Prostate Cancer RCT Consensus Group (2014)
Can we deliver randomized trials of focal therapy in prostate cancer?
Nat Rev Clin Oncol, 11 (8), 482-91
DOI 10.1038/nrclinonc.2014.44, PubMed 24751803

Baco E, Gelet A, Crouzet S, Rud E, Rouvière O, Tonoli-Catez H, Berge V, Chapelon JY, Eggesbø HB (2014)
Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study
BJU Int, 114 (4), 532-40
DOI 10.1111/bju.12545, PubMed 24930692

Baco E, Rud E, Ukimura O, Vlatkovic L, Svindland A, Matsugasumi T, Bernhard JC, Rewcastle JC, Eggesbø HB (2014)
Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer
Urol Oncol, 32 (8), 1300-7
DOI 10.1016/j.urolonc.2014.07.014, PubMed 25189687

Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, Matsugasumi T, Bernhard JC, Gill IS, Ukimura O (2014)
Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer
J Urol, 193 (2), 466-72
DOI 10.1016/j.juro.2014.08.084, PubMed 25150643

Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
Eur Urol, 67 (4), 787-94
DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973

Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU (2014)
Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting
Eur Urol, 67 (4), 771-7
DOI 10.1016/j.eururo.2014.09.018, PubMed 25281389

Rud E, Baco E, Lien D, Klotz D, Eggesbø HB (2014)
Detection of radiorecurrent prostate cancer using diffusion-weighted imaging and targeted biopsies
AJR Am J Roentgenol, 202 (3), W241-6
DOI 10.2214/AJR.12.10483, PubMed 24555620

Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Siddiqui H, Lagesen K, Nederbragt AJ, Eri LM, Jeansson SL, Jakobsen KS (2014)
Pathogens in Urine from a Female Patient with Overactive Bladder Syndrome Detected by Culture-independent High Throughput Sequencing: A Case Report
Open Microbiol J, 8, 148-53
DOI 10.2174/1874285801408010148, PubMed 25685246

Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, Eri LM (2013)
A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up
Urology, 81 (4), 781-6
DOI 10.1016/j.urology.2013.01.017, PubMed 23465150

Berge V, Dickinson L, McCartan N, Hindley RG, Diep LM, Emberton M, Ahmed HU (2013)
Morbidity associated with primary high intensity focused ultrasound and redo high intensity focused ultrasound for localized prostate cancer
J Urol, 191 (6), 1764-9
DOI 10.1016/j.juro.2013.12.036, PubMed 24373800

Brennhovd B, Axcrona K, Fosså SD, Giercksky KE, Vlatkovic L, Dahl AA (2013)
Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events
Scand J Urol, 47 (6), 449-55
DOI 10.3109/21681805.2013.780257, PubMed 24328733

Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B (2013)
Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients
Acta Oncol, 52 (8), 1771-7
DOI 10.3109/0284186X.2013.765065, PubMed 23398621

Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG (2013)
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
Cancer Res, 73 (16), 5277-87
DOI 10.1158/0008-5472.CAN-13-0549, PubMed 23720054

Frøen H, Brennhovd B, Abeler VM, Madsbu UE, Lehne G (2012)
[Young man with severe back pain]
Tidsskr Nor Laegeforen, 132 (14), 1626-9
DOI 10.4045/tidsskr.11.1059, PubMed 22875130

Hole KH, Axcrona K, Lie AK, Vlatkovic L, Geier OM, Brennhovd B, Knutstad K, Olsen DR, Seierstad T (2012)
Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
Eur Radiol, 23 (4), 1158-66
DOI 10.1007/s00330-012-2669-x, PubMed 23114883

Rud E, Baco E, Eggesbø HB (2012)
MRI and ultrasound-guided prostate biopsy using soft image fusion
Anticancer Res, 32 (8), 3383-9
PubMed 22843919

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Axcrona K, Vlatkovic L, Hovland J, Brennhovd B, Kongsgaard U, Giercksky KE (2011)
Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
J Robot Surg, 6 (1), 81-3
DOI 10.1007/s11701-011-0270-y, PubMed 22408687

Berge V (2011)
Editorial comment to transrectal high-intensity focused ultrasound for treatment of localized prostate cancer
Int J Urol, 18 (5), 363-4
DOI 10.1111/j.1442-2042.2011.02752.x, PubMed 21453400

Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
Int J Urol, 18 (9), 646-51
DOI 10.1111/j.1442-2042.2011.02815.x, PubMed 21771102

Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM (2011)
Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
Scand J Urol Nephrol, 46 (1), 8-13
DOI 10.3109/00365599.2011.604790, PubMed 21843041

Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K (2011)
Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
BJU Int, 110 (2 Pt 2), E69-75
DOI 10.1111/j.1464-410X.2011.10759.x, PubMed 22093091

Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
Nutr Cancer, 63 (6), 889-98
DOI 10.1080/01635581.2011.582221, PubMed 21714686

Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA (2011)
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
Mol Cancer, 10, 50
DOI 10.1186/1476-4598-10-50, PubMed 21548940

Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2011)
Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
BJU Int, 109 (9), 1366-74
DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333

Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S (2011)
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
Prostate, 72 (6), 668-76
DOI 10.1002/pros.21470, PubMed 21809351

Wedde TB, Lobmaier IV, Brennhovd B, Lohne F, Hall KS (2011)
Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man
Sarcoma, 2011, 978319
DOI 10.1155/2011/978319, PubMed 21776194

Axcrona K, Brennhovd B, Andersen M, Berner A (2010)
Sarcomatoid squamous cell carcinoma of the penis
Acta Oncol, 49 (1), 128-30
DOI 10.3109/02841860903246565, PubMed 20100148

Berge V, Baco E, Karlsen SJ (2010)
A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results
Scand J Urol Nephrol, 44 (4), 223-7
DOI 10.3109/00365591003727551, PubMed 20350272

Nøkleby K, Berge V, Stiris M, Tufteland KF, Humerfelt S (2010)
[A 40ish man with weight loss and scrotum edema]
Tidsskr Nor Laegeforen, 130 (20), 2026-8
DOI 10.4045/tidsskr.09.0486, PubMed 20967042

Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2010)
Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
Acta Oncol, 50 (3), 408-14
DOI 10.3109/0284186X.2010.492236, PubMed 20586661

Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
[Incorrect about hormone treatment in prostatic cancer]
Tidsskr Nor Laegeforen, 129 (5), 429
DOI 10.4045/tidsskr.08.0649, PubMed 19247406

Marangos IP, Kazaryan AM, Rosseland AR, Røsok BI, Carlsen HS, Kromann-Andersen B, Brennhovd B, Hauss HJ, Giercksky KE, Mathisen Ø, Edwin B (2009)
Should we use laparoscopic adrenalectomy for metastases? Scandinavian multicenter study
J Surg Oncol, 100 (1), 43-7
DOI 10.1002/jso.21293, PubMed 19431158

Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T (2007)
Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis
Scand J Urol Nephrol, 41 (6), 507-10
DOI 10.1080/00365590701428590, PubMed 17853049

Berge V, Thompson T, Blackman D (2007)
Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting
Scand J Urol Nephrol, 41 (3), 198-203
DOI 10.1080/00365590601016677, PubMed 17469027

Berge V, Thompson T, Blackman D (2006)
Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waiting
Eur Urol, 52 (4), 1036-43
DOI 10.1016/j.eururo.2006.12.012, PubMed 17178188

Brennhovd B, Johnsrud K, Berner A, Bogsrud T, Waehre H, Giercksky KE, Axcrona K (2006)
Sentinel node procedure in low-stage/low-grade penile carcinomas
Scand J Urol Nephrol, 40 (3), 204-7
DOI 10.1080/00365590600589971, PubMed 16809260

Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S (2005)
[Markers for diagnosis, prediction and prognosis of prostate cancer]
Tidsskr Nor Laegeforen, 125 (23), 3279-82
PubMed 16327854

Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ (2003)
Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study
J Urol, 170 (1), 226-9
DOI 10.1097/01.ju.0000060782.52358.04, PubMed 12796694

Thiem B, Berge V (2003)
[Cloudberry: an important source of ellagic acid, an anti-oxidant]
Tidsskr Nor Laegeforen, 123 (13-14), 1856-7
PubMed 12830265

Eri LM, Thomassen H, Brennhovd B, Håheim LL (2002)
Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
Prostate Cancer Prostatic Dis, 5 (4), 273-8
DOI 10.1038/sj.pcan.4500568, PubMed 12627211

Eri LM, Wessel N, Tysland O, Berge V (2002)
Comparative study of pressure-flow parameters
Neurourol Urodyn, 21 (3), 186-93
DOI 10.1002/nau.10018, PubMed 11948710

Eri LM, Sivertsen S, Nagelhus J (2001)
The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery
World J Urol, 19 (4), 256-8
PubMed 11550784

Eri LM, Svindland A, Tveter KJ (2001)
The effect of bicalutamide on prostate histology
Prostate, 46 (4), 275-80
DOI 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2, PubMed 11241549

Eri LM, Tveter KJ (2001)
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
Prostate Cancer Prostatic Dis, 4 (3), 173-177
DOI 10.1038/sj.pcan.4500504, PubMed 12497037

Eri LM, Wessel N, Berge V (2001)
Test-retest variation of pressure flow parameters in men with bladder outlet obstruction
J Urol, 165 (4), 1188-92
DOI 10.1016/S0022-5347(05)66466-X, PubMed 11257668

Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
No randomised trial of prostate-cancer screening in Norway
Lancet Oncol, 2 (12), 741-5; discussion 746-9
DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516

Eri LM, Svindland A (2000)
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Urology, 56 (2), 261-5
DOI 10.1016/s0090-4295(00)00629-4, PubMed 10925090

Nesbakken A, Nygaard K, Bull-Njaa T, Carlsen E, Eri LM (2000)
Bladder and sexual dysfunction after mesorectal excision for rectal cancer
Br J Surg, 87 (2), 206-10
DOI 10.1046/j.1365-2168.2000.01357.x, PubMed 10671929

Fosså SD, Eri LM (1999)
[Timely screening routines for prostatic cancer by Norwegian physicians]
Tidsskr Nor Laegeforen, 119 (24), 3572-6
PubMed 10563174

Eri LM, Tveter KJ (1997)
Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective
Drugs Aging, 10 (2), 107-18
DOI 10.2165/00002512-199710020-00004, PubMed 9061268

Eri LM, Haug E, Tveter KJ (1996)
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia
Scand J Clin Lab Invest, 56 (4), 319-25
DOI 10.3109/00365519609090583, PubMed 8837238

Eri LM, Wahlqvist R, Tveter KJ (1996)
[Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society]
Tidsskr Nor Laegeforen, 116 (27), 3240-4
PubMed 9011979

Svindland A, Eri LM, Tveter KJ (1996)
Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome
Scand J Urol Nephrol Suppl, 179, 113-7
PubMed 8908676

Berge V, Eri LM, Tveter KJ (1995)
Complications of invasive, urodynamic examinations and prostate biopsies in patients with benign prostatic hyperplasia
Scand J Urol Nephrol Suppl, 172, 95-8
PubMed 8578262

Eri LM, Haug E, Tveter KJ (1995)
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia
Br J Urol, 75 (3), 335-40
DOI 10.1111/j.1464-410x.1995.tb07345.x, PubMed 7537602

Eri LM, Tveter KJ (1995)
alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia
J Urol, 154 (3), 923-34
DOI 10.1016/S0022-5347(01)66936-2, PubMed 7543612

Eri LM, Urdal P (1995)
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
Eur Urol, 27 (4), 274-9
DOI 10.1159/000475180, PubMed 7544732

Eri LM, Urdal P, Bechensteen AG (1995)
Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia
J Urol, 154 (1), 100-4
DOI 10.1016/S0022-5347(01)67239-2, PubMed 7539852

Eri LM, Tveter KJ (1994)
Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia
Eur Urol, 26 (3), 219-26
DOI 10.1159/000475384, PubMed 7528662

Eri LM, Tveter KJ (1994)
Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia
J Urol, 152 (2 Pt 1), 448-52
DOI 10.1016/s0022-5347(17)32760-x, PubMed 7516978

Eri LM, Tveter KJ (1993)
A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia
J Urol, 150 (1), 90-4
DOI 10.1016/s0022-5347(17)35406-x, PubMed 7685428

Eri LM, Tveter KJ (1993)
A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia
J Urol, 150 (2 Pt 1), 359-64
DOI 10.1016/s0022-5347(17)35483-6, PubMed 7686981

Eri LM, Tveter KJ (1992)
Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia
Eur Urol, 22 (1), 9-13
DOI 10.1159/000474714, PubMed 1385147

Eri LM, Tveter KJ (1992)
Measuring the quality of life of patients with benign prostatic hyperplasia. Assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients
Eur Urol, 21 (4), 257-62
DOI 10.1159/000474853, PubMed 1281101

Eri LM, Harbitz TB, Løtveit T (1988)
Pseudocyst of the spleen after closed abdominal injury
Injury, 19 (4), 297
DOI 10.1016/0020-1383(88)90057-5, PubMed 3229854

Eri LM, Klevmark B (1988)
[Urethral diverticulum in women]
Tidsskr Nor Laegeforen, 108 (12), 925-7
PubMed 3132747

Eri LM, Klevmark B (1988)
[Primary megaureter in adults]
Tidsskr Nor Laegeforen, 108 (12), 930-2
PubMed 3381207

Klevmark B, Talseth T, Eri LM, Borchgrevink HH, Kolbenstvedt A (1988)
[Congenital curvature of the erect penis without simultaneous changes in the urethra or corpus spongiosum and with normal erection]
Tidsskr Nor Laegeforen, 108 (8-9), 683-5
PubMed 3353973

Klevmark B, Talseth T, Eri LM, Kolbenstvedt A, Egge T (1988)
Abnormal venous drainage from the penis examined by dynamic cavernosography and surgically treated
Scand J Urol Nephrol Suppl, 110, 261-5
PubMed 3187421

Klevmark B, Talseth T, Eri LM, Kolbenstvedt AN (1988)
[Erectile impotence and disorders of venous circulation]
Tidsskr Nor Laegeforen, 108 (8-9), 679-80
PubMed 3353971

Eri LM, Gjengedal E (1987)
[Surgical treatment of the impingement syndrome]
Tidsskr Nor Laegeforen, 107 (6), 543-4
PubMed 3576543

Eri LM, Liavåg I (1987)
[Subtotal cholecystectomy. An alternative to a difficult cholecystectomy]
Tidsskr Nor Laegeforen, 107 (5), 467-8
PubMed 3576533

Eri LM, Sander S (1986)
[Primary hyperparathyroidism. Surgical case material from Aker Hospital 1974-85]
Tidsskr Nor Laegeforen, 106 (12), 1028-30
PubMed 3726830

Eri LM, Sander S, Rostad B, Bay D (1986)
[Preoperative localization of parathyroid tumors. CT and ultrasonics before surgery of primary hyperparathyroidism]
Tidsskr Nor Laegeforen, 106 (12), 1042-5
PubMed 3523823

Gjengedal E, Rolfsen L, Eri LM (1986)
[Acute total dislocation of the acromioclavicular joint. Surgical treatment]
Tidsskr Nor Laegeforen, 106 (30), 2515-7, 2530
PubMed 3798429

Eri LM, Hoel R (1985)
[Adenocarcinoma of the colon and rectum. A population study]
Tidsskr Nor Laegeforen, 105 (9-10), 665-8
PubMed 3992555

Eri LM, Hvaal K, Gjølberg TO (1985)
[Percutaneous transluminal angioplasty in the lower limbs]
Tidsskr Nor Laegeforen, 105 (7), 503-6
PubMed 3158096

Eri LM, Drabløs PA (1984)
[Inguinal hernia in children. Case material from a central hospital]
Tidsskr Nor Laegeforen, 104 (2), 81-3
PubMed 6701841

 
Page visits: 5714